Citation Impact
Citing Papers
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
A review of wide surgical excision of hidradenitis suppurativa
2012
Ex vivo high‐definition optical coherence tomography of basal cell carcinoma compared to frozen‐section histology in micrographic surgery: a pilot study
2012
T cell exhaustion: from pathophysiological basics to tumor immunotherapy
2017
Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review
2017
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Hidradenitis Suppurativa: An Update
2007
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Smokers Report More Psoriasis, but Not Atopic Dermatitis or Hand Eczema: Results from a Norwegian Population Survey among Adults
2007
Etanercept: effective in the management of hidradenitis suppurativa
2006
Hidradenitis suppurativa: pathogenesis and management
2003
Hidradenitis suppurativa: a review
2004
Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity
2009 Standout
Efficacy of Lymphatic Mapping, Sentinel Lymphadenectomy, and Selective Complete Lymph Node Dissection as a Therapeutic Procedure for Early-Stage Melanoma
1999
Long-term efficacy of a single course of infliximab in hidradenitis suppurativa
2007
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
2008 Standout
Incidence of Hidradenitis Suppurativa and Associated Factors: A Population-Based Study of Olmsted County, Minnesota
2012 Standout
Hidradenitis Suppurativa
2012 Standout
Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial
2010
Hidradenitis suppurativa: A comprehensive review
2009 Standout
Current and future adjuvant immunotherapies for melanoma: Blockade of cytotoxic T-lymphocyte antigen-4 as a novel approach
2010
Recognition, diagnosis, and treatment of primary focal hyperhidrosis
2004 Standout
Hidradenitis Suppurativa: Importance of Early Treatment; Efficient Treatment with Electrosurgery
2007
Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa
2011 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
2019 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Cutaneous Effects of Smoking
2004
Painful Hidradenitis Suppurativa
2010
Surgical Treatment of Hidradenitis Suppurativa with Gentamicin Sulfate: A Prospective Randomized Study
2007
Randomized Control Trial for the Treatment of Hidradenitis Suppurativa with a Neodymium-Doped Yttrium Aluminium Garnet Laser
2009
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Experience with different treatment modules in hidradenitis suppuritiva: A study of 106 cases
2005
Sentinel-Node Biopsy or Nodal Observation in Melanoma
2006 Standout
The Influence of Body Weight on the Prevalence and Severity of Hidradenitis Suppurativa
2014
Acne inversa
2007
Real-Time Compound Imaging Ultrasound of Hidradenitis Suppurativa
2007
Absorption of chemicals through compromised skin
2009
Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature
2017
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
2016
Mild to moderate hidradenitis suppurativa treated with local excision and primary closure
2011
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
2012 Standout
Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)
2000
Efficacy of Rifampin-Moxifloxacin-Metronidazole Combination Therapy in Hidradenitis Suppurativa
2010
Increased Prevalence of Metabolic Syndrome in Patients with Acne Inversa
2012
Pyroptosis: mechanisms and diseases
2021 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
2015
Acne vulgaris
2011 Standout
Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser
2010
Clinicopathological Study of 13 Cases of Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa
2009
A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa
2011
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
2017 Standout
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
2016 Standout
Psychosocial Impact of Hidradenitis Suppurativa: A Qualitative Study
2011
Hidradenitis suppurativa: A retrospective study of 846 Dutch patients to identify factors associated with disease severity
2014
Treatment of Hidradenitis Suppurativa with Tumour Necrosis Factor-alpha Inhibitors
2009
Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies
2008 Standout
The development of immunomodulatory monoclonal antibodies as a new therapeutic modality for cancer: The Bristol-Myers Squibb experience
2014
Melanoma
2015
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline
2015
Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial
2002
Hidradenitis suppurativa
2020 Standout
Hidrosadénite axillaire : une stratégie thérapeutique en un temps
2011
Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser
2008
Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β
2011 Standout
PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment
2022 StandoutNobel
Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study
2009
The etiology, diagnosis, and management of hyperhidrosis: A comprehensive review
2019
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Optische Kohärenztomographie
2015 Standout
Surgical Procedures in Hidradenitis Suppurativa
2015
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
2015 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma Patients
1999
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
2015 Standout
Physiology of sweat gland function: The roles of sweating and sweat composition in human health
2019 Standout
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
2001 Standout
Practical Management of Hidradenitis Suppurativa
2008
Prospective Open-Label Study of Botulinum Toxin Type A in Patients with Axillary Hyperhidrosis: Effects on Functional Impairment and Quality of Life
2006
Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma
2018
Treatment of axillary hyperhidrosis
2002
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Risk factors, clinical course and long‐term prognosis in hidradenitis suppurativa: a cross‐sectional study
2014
Acne inversa (alias hidradenitis suppurativa)
2001
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Recommendations for the management of comorbidity in hidradenitis suppurativa
2017
Hidradenitis Suppurativa
2003
Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa
2012 Standout
Potential Health Effects Associated with Dermal Exposure to Occupational Chemicals
2014 Standout
Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa
2011
What causes hidradenitis suppurativa?
2008
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
2001 Standout
Hidradenitis Suppurativa
2008
A Systematic Review of Treatments for Hidradenitis Suppurativa
2011
Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review
2017
Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
2011
Incidence of cancer among patients with hidradenitis suppurativa.
2001
Manejo práctico de la hidrosadenitis supurativa
2008
Works of Rainer Rompel being referenced
Subcutaneous curettage for the treatment of axillaryhyperhidrosis
2000
Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma
2015
Cigarette Smoking as a Triggering Factor of Hidradenitis suppurativa
1999
Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis
2001
Treatment modalities for allergic reactions in pigmented tattoos
2007
Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma
2015
COX-2 expression in malignant melanoma: a novel prognostic marker?
2009
A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up
2011
Botulinum toxin for treatment of craniofacial hyperhidrosis
2000
Microscopically controlled surgery (MCS)
2010
Role of Elective Lymph Node Dissection in Stage I Malignant Melanoma: Evaluation by Matched Pair Analysis
1995
Elective lymph node dissection in primary malignant melanoma
1995
Long-Term Results of Wide Surgical Excision in 106 Patients with Hidradenitis Suppurativa
2000
S1 guideline: microscopically controlled surgery (MCS)
2015
Prospective Randomized Multicenter Adjuvant Dermatologic Cooperative Oncology Group Trial of Low-Dose Interferon Alfa-2b With or Without a Modified High-Dose Interferon Alfa-2b Induction Phase in Patients With Lymph Node–Negative Melanoma
2009
Mikroskopisch kontrollierte Chirurgie (MKC)
2010
Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
2014